Clinical TrialsSearch results
Number of results: 2568
Recruiting
- WRAP study
- Pancreatic body/tail region disease
- Takahashi Yu
- 2024-06-15
Recruiting
- A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (PROCEED)
- Migraine
- Yazawa Masanari
- 2024-06-14
Not yet recruiting
- Tactile Massage to Stimulate Melatonin Secretion
- Healthy person Expected effect: Improvement of sleep quality
- Hattori Atsuhiko
- 2024-06-13
Recruiting
- JCOG2205: Sustainable and Efficient Platform of New Therapeutic Development for Early Breast Cancer (S-FACT)
- Clinical stage II or III, resectable breast cancer
- Yonemori Kan
- 2024-06-13
Recruiting
- JCOG2205-TN-1: Sustainable and Efficient Platform of New Therapeutic Development for Early Breast Cancer (S-FACT) Triple-negative breast cancer cohort (TN-1)
- Clinical stage II or III, resectable breast cancer
- Yonemori Kan
- 2024-06-13
Recruiting
- Follow-up study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass grafting
- Heart failure with ischemic heart disease
- Kaneko Takehiko
- 2024-06-13
Recruiting
- Comparison of hemodynamics between Evolut and Sapien in transcatheter biological valves in dialysis patients
- Aortic valve stenosis
- Tabata Minoru
- 2024-06-13
Recruiting
- A Non-Inferiority Randomized Controlled Trial and Prospective Cohort Study Comparing Clinical Outcomes of Unilateral Biportal Endoscopic Surgery Utilizing the Interlaminar Approach Versus the Transforaminal Approach in Patients with Lumbar Disc Herniation
- Lumbar disc herniation
- Segawa Tomohide
- 2024-06-13
Other
- A Retrospective Study of the Usefulness of Hydrocortisone Prophylaxis for Oxaliplatin-induced Hypersensitivity Reactions
- gastrointestinal cancer
- Nishimura Takahiro
- 2024-06-11
Not yet recruiting
- Use-result survey of Daichirona for intramuscular injection
- Prevention of SARS-CoV-2 infection
- Tanabe Hirokazu
- 2024-06-11